Idiopathic anterior uveitis - is it a rheumatic disease?
Journal Title: Reumatologia - Year 2006, Vol 44, Issue 6
Abstract
Anterior uveitis is an acute, recurrent, sight-threatening disease that in 20% of patients leads to severe visual loss or blindness. 60% of patients with anterior uveitis have additional manifestations of systemic disease; in 85% of them spondyloarthropathy (SpA) can be diagnosed. However, up to 30% of patients with anterior uveitis cannot be diagnosed with any associated disease. We studied 20 patients (11 men, 9 women, mean age 34 yrs) with recurrent, non-exogenous, sight-threatening AU. Rheumatic disease was diagnosed in 9 (45%) patients; all of them were diagnosed as seronegative spondylarthropathy. 17 (85%) patients agreed for treatment with disease-modifying anti-rheumatic drugs (DMARDs). The drug of first choice was cyclosporin A. The treatment period was at least 11 months. We observed relapse in 4 patients during treatment. 13 patients are still in remission. On the basis of cumulative proportion analysis we confirmed significant extension of remission period during treatment compared with mean remission period before treatment. We concluded that treatment with DMARDs in patients with anterior uveitis led to significant extension of remission period, independently of systemic disease diagnosis.
Authors and Affiliations
Artur Bachta, Mateusz Tłustochowicz
Keywords
Related Articles
- EP ID EP128866
- DOI -
- Views 59
- Downloads 0
Chronic viral hepatitis as the cause of arthritis
The aim of the study was to assess rheumatic symptoms and their correlations with transaminases activity in patients with chronic viral hepatitis. 80 patients with chronic hepatitis (30 female and 50 male of mean age 43....
The value of the assessment of interleukin-6 (IL-6), matrix metalloproteinases and their inhibitors in serum in the assessment of rheumatoid arthritis activity
The aim of the study was to explore whether the serum level of interleukin 6 (IL-6) is correlated with matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and with clinical markers of th...
Early outcome of patients with rheumatoid arthritis treated with infliximab
The aim of this study was to analyse the outcome of patients with rheumatoid arthritis (RA) treated with infliximab. Thirty-one patients (3 male, 28 female), aged 50 years (range 22-67 years), treated in a single insti...
Cardiovascular system involvement in systemic lupus erythematosus - review and own observation. Serological risk factor of cardiological complications
Systemic lupus erythematosus is an autoimmune disease, in the course of which involvement of the circulatory system is one of the common systemic manifestations, very important from the prognostic point of view. Involvem...
Metody oceny aktywności twardziny układowej
Rozpoznanie twardziny układowej (TU) nie zawsze jest łatwe, szczególnie we wczesnym okresie choroby. Ma to związek z dużą zmiennością rozległości zmian skórnych, różnym stopniem zajęcia narządów wewnętrznych, bardzo zmie...